Generic placeholder image

Mini-Reviews in Medicinal Chemistry


ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

ACE Inhibitor-Angiotensin Receptor Blocker Combinations: A Clinicians Perspective

Author(s): T. W.R. Doulton

Volume 6, Issue 5, 2006

Page: [491 - 497] Pages: 7

DOI: 10.2174/138955706776876168

Price: $65


ACE Inhibitors (ACEI) and angiotensin receptor blockers (ARB) inhibit the renin-angiotensin system, but ACEI may do so incompletely when administered as monotherapy at conventional doses. In theory, combining an ACEI and ARB might be beneficial, whereas clinical evidence for this approach in hypertension is lacking. An ACEI-ARB combination is likely to be useful in proteinuric renal disease, but recent experimental evidence suggests that very high dose monotherapy with an ARB may be the best approach. However, the results of large outcome studies for combinations vs. ACEI or ARB monotherapy are still awaited.

Keywords: Renin-angiotensin system, angiotensin converting enzyme (ACE) inhibitor, angiotensin-receptor blocker, hypertension, diabetic nephropathy, chronic kidney disease, proteinuria

Next »

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy